312 related articles for article (PubMed ID: 34826438)
21. miR-215-5p is an anticancer gene in multiple myeloma by targeting RUNX1 and deactivating the PI3K/AKT/mTOR pathway.
Liu S; Zhang Y; Huang C; Lin S
J Cell Biochem; 2020 Feb; 121(2):1475-1490. PubMed ID: 31498483
[TBL] [Abstract][Full Text] [Related]
22. Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway.
Li M; Zhang Z; Hill DL; Wang H; Zhang R
Cancer Res; 2007 Mar; 67(5):1988-96. PubMed ID: 17332326
[TBL] [Abstract][Full Text] [Related]
23. Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression.
Xia A; Li H; Li R; Lu L; Wu X
Oncol Rep; 2018 Oct; 40(4):2353-2362. PubMed ID: 30066933
[TBL] [Abstract][Full Text] [Related]
24. Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways.
Chen SR; Cai WP; Dai XJ; Guo AS; Chen HP; Lin GS; Lin RS
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3461-3470. PubMed ID: 31081101
[TBL] [Abstract][Full Text] [Related]
25. Peruvoside targets apoptosis and autophagy through MAPK Wnt/β-catenin and PI3K/AKT/mTOR signaling pathways in human cancers.
Reddy D; Kumavath R; Tan TZ; Ampasala DR; Kumar AP
Life Sci; 2020 Jan; 241():117147. PubMed ID: 31830480
[TBL] [Abstract][Full Text] [Related]
26. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
[TBL] [Abstract][Full Text] [Related]
27. Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
Yin F; Huang X; Xuan Y
Dis Markers; 2021; 2021():9950663. PubMed ID: 34512817
[TBL] [Abstract][Full Text] [Related]
28. Synergistic growth inhibition mediated by dual PI3K/mTOR pathway targeting and genetic or direct pharmacological AKT inhibition in human glioblastoma models.
von Achenbach C; Weller M; Kaulich K; Gramatzki D; Zacher A; Fabbro D; Reifenberger G; Szabó E
J Neurochem; 2020 May; 153(4):510-524. PubMed ID: 31618458
[TBL] [Abstract][Full Text] [Related]
29. 2-(2-(2,4-dioxopentan-3-ylidene)hydrazineyl)benzonitrile as novel inhibitor of receptor tyrosine kinase and PI3K/AKT/mTOR signaling pathway in glioblastoma.
Viswanathan A; Kute D; Musa A; Konda Mani S; Sipilä V; Emmert-Streib F; Zubkov FI; Gurbanov AV; Yli-Harja O; Kandhavelu M
Eur J Med Chem; 2019 Mar; 166():291-303. PubMed ID: 30731398
[TBL] [Abstract][Full Text] [Related]
30. The effect of miR-579 on the PI3K/AKT pathway in human glioblastoma PTEN mutant cell lines.
Kalhori MR; Irani S; Soleimani M; Arefian E; Kouhkan F
J Cell Biochem; 2019 Oct; 120(10):16760-16774. PubMed ID: 31243804
[TBL] [Abstract][Full Text] [Related]
31. Nitidine chloride inhibits the malignant behavior of human glioblastoma cells by targeting the PI3K/AKT/mTOR signaling pathway.
Liu M; Wang J; Qi Q; Huang B; Chen A; Li X; Wang J
Oncol Rep; 2016 Oct; 36(4):2160-8. PubMed ID: 27498786
[TBL] [Abstract][Full Text] [Related]
32. Antitumor effect of lenalidomide in malignant glioma cell lines.
Hanashima Y; Sano E; Sumi K; Ozawa Y; Yagi C; Tatsuoka J; Yoshimura S; Yamamuro S; Ueda T; Nakayama T; Hara H; Yoshino A
Oncol Rep; 2020 May; 43(5):1580-1590. PubMed ID: 32323826
[TBL] [Abstract][Full Text] [Related]
33. Punicic Acid Inhibits Glioblastoma Migration and Proliferation via the PI3K/AKT1/mTOR Signaling Pathway.
Mete M; Ünsal ÜÜ; Aydemir I; Sönmez PK; Tuglu MI
Anticancer Agents Med Chem; 2019; 19(9):1120-1131. PubMed ID: 30950355
[TBL] [Abstract][Full Text] [Related]
34. RRAGB-mediated suppression of PI3K/AKT exerts anti-cancer role in glioblastoma.
Li Q; Liu X; Mao J; Liu S; Hou B; Li K; Fang D
Biochem Biophys Res Commun; 2023 Oct; 676():149-157. PubMed ID: 37517217
[TBL] [Abstract][Full Text] [Related]
35. F-box protein FBXO31 modulates apoptosis and epithelial-mesenchymal transition of cervical cancer via inactivation of the PI3K/AKT-mediated MDM2/p53 axis.
Liu K; Xue B; Bai G; Zhang W
Life Sci; 2020 Oct; 259():118277. PubMed ID: 32800832
[TBL] [Abstract][Full Text] [Related]
36. Rapamycin-mediated mTOR inhibition attenuates survivin and sensitizes glioblastoma cells to radiation therapy.
Anandharaj A; Cinghu S; Park WY
Acta Biochim Biophys Sin (Shanghai); 2011 Apr; 43(4):292-300. PubMed ID: 21367753
[TBL] [Abstract][Full Text] [Related]
37. Effects of Fibronectin 1 on Cell Proliferation, Senescence and Apoptosis of Human Glioma Cells Through the PI3K/AKT Signaling Pathway.
Liao YX; Zhang ZP; Zhao J; Liu JP
Cell Physiol Biochem; 2018; 48(3):1382-1396. PubMed ID: 30048971
[TBL] [Abstract][Full Text] [Related]
38. Kaempferol inhibits proliferation, migration, and invasion of liver cancer HepG2 cells by down-regulation of microRNA-21.
Zhu G; Liu X; Li H; Yan Y; Hong X; Lin Z
Int J Immunopathol Pharmacol; 2018; 32():2058738418814341. PubMed ID: 30477356
[TBL] [Abstract][Full Text] [Related]
39. Antiproliferative Activity of Carnosic Acid is Mediated via Inhibition of Cell Migration and Invasion, and Suppression of Phosphatidylinositol 3-Kinases (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway.
Zhao L; Zhang J; Fan Y; Li Y
Med Sci Monit; 2019 Oct; 25():7864-7871. PubMed ID: 31631173
[TBL] [Abstract][Full Text] [Related]
40. Cell surface area and membrane folding in glioblastoma cell lines differing in PTEN and p53 status.
Memmel S; Sukhorukov VL; Höring M; Westerling K; Fiedler V; Katzer A; Krohne G; Flentje M; Djuzenova CS
PLoS One; 2014; 9(1):e87052. PubMed ID: 24498019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
